S7C.F STENOCARE DK-08
- Market cap
- EUR 3.60M
- P/E
- -
- P/B
- 3.40x
- ROE
- -26.6%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is S7C.F undervalued?
Graham numberThe Graham number of STENOCARE DK-08 cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
STENOCARE DK-08 fundamental analysis
No fundamental analysis for STENOCARE DK-08 yet.
STENOCARE DK-08 stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About STENOCARE DK-08
Stenocare A/S cultivates, produces, imports, distributes, and sells prescription-based medical cannabis products to patients in Denmark and internationally. It offers medical cannabis oil products, including THC, THC/CBD, and CBD, as well as CBD100 oil products. The company was incorporated in 2017 and is based in Randers, Denmark.
Full company profileSTENOCARE DK-08 financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
STENOCARE DK-08 annual financial statements (DKK; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 1.58M | 4.49M | 3.76M | 2.23M | 7.02M | 13.2M |
| Gross Profit | -5.76M | -6.41M | -6.19M | 18.5M | 1.22M | - |
| Operating Income | -14.1M | -16.5M | -15.9M | 3.86M | -1.77M | -1.75M |
| EBITDA | - | -13.3M | -12.6M | -24.2M | -1.66M | -170K |
| Net Income | -12.7M | -16.3M | -17.6M | -34.5M | -2.39M | -2.12M |
| EPS | -0.59 | -0.75 | -0.54 | -0.96 | -0.06 | -0.05 |
| Balance Sheet | ||||||
| Total Assets | 43.9M | 39.6M | 38.1M | 19.4M | 12.6M | 11.1M |
| Total Liabilities | 3.69M | 15.5M | 12.3M | 22.9M | 3.17M | 3.09M |
| Shareholders' Equity | 40.2M | 24.1M | 25.8M | -3.47M | 9.47M | 7.99M |
| Cash & Short-term Investments | 11.7M | 4.43M | 9.50M | 1.38M | 787K | 568K |
| Cash Flow | ||||||
| Operating Cash Flow | -13.3M | -15.0M | -10.0M | -7.14M | -7.20M | 1.08M |
| Capital Expenditure | 3.27M | 936K | 176K | 44.4K | 0.00 | 0.00 |
| Free Cash Flow | -16.6M | -16.0M | -10.2M | -7.19M | -7.20M | 1.08M |
| Ratios | ||||||
| ROE | -31.6% | -67.5% | -68.0% | - | -25.2% | -26.6% |
| ROA | -29.0% | -41.2% | -46.1% | -177.4% | -18.9% | -19.2% |
| Net Profit Margin | -808.4% | -363.1% | -467.5% | -1,545.1% | -34.0% | -16.0% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
STENOCARE DK-08 dividends
STENOCARE DK-08 has not paid dividends in the last 5 fiscal years.
Who owns STENOCARE DK-08
- Insiders 20.01%
- Institutions 0.00%
- Public & others 79.99%
- Shares outstanding 43.2M
- Free float 33.0M
STENOCARE DK-08 company profile
- Company name
- STENOCARE DK-08
- Ticker
- S7C.F
- ISIN
- DK0061078425
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Employees
- 4
- Fiscal year end
- December
- Address
- Nyholmsvej 4, Randers, Denmark, 8930
- Phone
- 45 31 77 00 60
- Website
- stenocare.dk
About STENOCARE DK-08
Stenocare A/S cultivates, produces, imports, distributes, and sells prescription-based medical cannabis products to patients in Denmark and internationally. It offers medical cannabis oil products, including THC, THC/CBD, and CBD, as well as CBD100 oil products. The company was incorporated in 2017 and is based in Randers, Denmark.
STENOCARE DK-08 management
3- Mr. Thomas Skovlund SchnegelsbergCEO, Co-Founder & Member of Executive Board · born 1965
- Mr. Rolf Steno PetersenCo-Founder, Chief Commercial Officer & Director · born 1965
- Mr. Peter Bugge JohansenChief Financial Officer · born 1962